Samsung Biologics : Decision on Acquisition of Tangible Assets

Report of Disclosure Revision

Revision Date

2022-07-19

1. Disclosure Documents in relation with Revision	Decision on Acquisition of Tangible Assets
2. Submission date of documents	2022-05-20
3. Reason for Revision	Conclusion of a land sales contract
4. Revised Information
information	before revision	after revision
2. Details of acquisition - Acquisition price (KRW)	426,022,798,554	426,021,964,070
5. Scheduled acquisition date	2025-04-30	2025-07-18
7. Other important matters related to investment judgment	- The above case is for the purchase of a site for the 2nd Bio Campus, and we have been selected as the preferred bidder and are in the process of negotiating to conclude a land sale contract. - The above '5. Scheduled Acquisition Date'is after the purchase price is paid in full, and as the preferential negotiation period related to the land sales contract is extended, a disclosure of correction will be made at the time the contract is concluded.	- The above case concerns the purchase of a site for the 2nd Bio Campus, and the Company concluded the land sales contract on July 18th, 2022. - The '5. Scheduled acquisition date' above is the expected date of full payment of the transaction price.

-

Decision on Acquisition of Tangible Assets

1. Type of asset to be acquired	Land & buildings
- Name of asset to be acquired	Songdo International City High-tech Industrial Cluster (C) Ki19 (430 Songdo-dong, Yeonsu-gu, Incheon)
2. Details of acquisition	Acquisition price (KRW)	426,021,964,070
Total assets (KRW)	7,970,010,786,863
Ratio to total assets (%)	5.35
Classified as a large-sized corporation?	Yes
3. Counterparty	Incheon Free Economic Zone Authority (IFEZ)
4. Purpose of acquisition	2nd BIO Campus site purchase
5. Scheduled acquisition date	2025-07-18
6. Date of board resolution (decision date)	2022-03-29
- Attendance of outside directors	Present (No.)	4
Absent (No.)	-
- Attendance of auditors (members of Audit Committee who are not outside directors)	-
7. Other matters to be factored into investment decisions
- The above case concerns the purchase of a site for the 2nd Bio Campus, and the Company concluded the land sales contract on July 18th, 2022. - The above total assets under 'Details of acquisition' are based on the consolidated financial statements as of the end of 2021. - The '5. Scheduled acquisition date' above is the expected date of full payment of the transaction price. - Details such as acquisition amount and scheduled acquisition date are subject to change later.
※ Related disclosure	-